Nath Bio-genes (india) Ltd. · NSE:NATHBIOGEN
Nath Bio-genes (india) — Q1 FY2025 Earnings Presentation
28 slides from Nath Bio-genes (india)'s earnings presentation, Aug 7, 2024
Slide 1: Cover letter to stock exchanges on unaudited results presentation
07th August 2024 The Manager-Listing The Manager- Listing BSE Limited National Stock Exchange of India Ltd., Phiroze Jeejeebhoy Towers, Exchange Plaza, Bandra-Kurla Complex Dalal Street, Bandra (E) Mumbai-400001 Mumbai-400051 BSE Code-537291 NSE Code-NATHBIOGEN Dear Sir/Madam, Subject- Presentation
Slide 2: Investor Presentation - Q1FY25
Investor Presentation - Q1FY25 Website www.nathbiogenes.com 1
Slide 3: Disclaimer
Disclaimer Certain statements in this document may be forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties like government actions, local political or economic developments, technological risks, and many other factors that could cause our actual
Slide 4: Competitive Positioning in a Tough Sector
Competitive Positioning in a Tough Sector Focus Area Winning Strategies Product Selection • Focus on Cotton, Wheat, Maize & Fodder Bajra • Build a dream-product basket with superior • Empower Stakeholders; Build long-term, loyal, and diversified products symbiotic relationships with our production •
Slide 5: What our Business Delivered in Last 7 Years
What our Business Delivered in Last 7 Years Average Selling Price (Rs/kg) is Increasing Revenue Growth (INR Cr) 1,311 CAGR 10% 333 192 480 209 128 FY18 FY24 FY18 FY24 Field Crops Vegetables 4
Slide 6: Tailor Made Products
Tailor Made Products Focus on disease Understand key and pest resistance farmer requirements based on deep market research. which automatically results in higher yield Nath Bio-Genes (India) Limited
Slide 7: Focused on R&D we produce genetically pure, premium seeds
Ka Focused on R&D we, % Produce Genetically Pure and Premium Quality Seeds Well Invested, DSIR recognized R&D Innovation Centers Nath Bio-Genes (India) Limited
Slide 8: Focused on Shareholder Value Creation
Focused on Shareholder Value Creation Product Differentiated Margin Expansion Growing Business Excellence Customer Growing EBITDA Strong Positions in Innovation and solution Experience margins through important crops that drive productivity efficient operations Expanding market reach and create valu
Slide 9: Farming Community's Testimonials
Farming Community’s Testimonials 8
Slide 10: Farmers on Khushi-27
Farmers on Khushi-27 sy 2 NATH S€eDS | Mel Ulot egeit-27 UH decclat fen el a te fret Jun aft saeced é aie tract aft afgar va : vaee es | Ht enor egett-27 A wot age E | -wedeas Hy (prea) Bio-Genes (India) Limited
Slide 11: Farmers on Golden-72
Farmers on Golden-72 ey Tel Lat Mesot-72 Ff Fst eteye Just fect EI Bah cial wpe ole’ UT ch ela G Ast aateeia aft 31eaT feel | € dims Te aa Lol | - HELE Vella, Ictiest (3ifSert) 10
Slide 12: Farmers on Super-27
- ; Farmers on Super-27 ol Hel Aste] FUe-27 Het Veci veia e | Te gen et sean gare fest 21 sera St JOR tl seeced fect tS rel at aTeT ait NATH SEEDS” - SUPER-27 (NBBH-27) NATH HYBRID BAJRA SEEDS ) ee 11
Slide 13: Farmers on Alexander
Farmers on Alexander ss ey faci rd: . _ a > NATH SeeDs sah hel lode ee 21 He Heat Ufeaect th fee ait | JOgw el Hel sal fren cht afar uxt fect e1 ALEXANDER ‘Sweet Pepper Ft Hybrid Seeds 12
Slide 14: Farmers on NCH-2561
Farmers on NCH-2561 se & ( aametterateessciamnéetsteararet — ) = | | HBT Hofatd Ver el Beh Tee ee OT aro were | ale Uolte ON ed ciel Ela €1 citearTa 1 asi sa fren & aga et afee sun fect 21 NCH-2561 Chili F1 Hybrid Seeds Rater ae, ae ll | Nath Bio-Genes (India) Limited 13
Slide 15: Farmers on Nath Sanket
Farmers on “Nath Sanket” ‘oneal Beha Se Uw Taeced GUS Wont el wa edd H Ae Mal TUT cell el fee va eT ® Mia Gectelter elat th Hrevy carsal HT warded. NBC 1111 BG Il Cotton Hybrid Seeds with Bollgard If Technology 18
Slide 16: Farmers on Super-27
i» a Farmers on “Super-27” Mel HT Ase FTTe-27 UH WaeGeT AIT €. Bers fee otet vd and & sie yun aft Haeced fact . TUT & ores Tre th fer aft TECH INA Ws... i (NBBH-27) NATH HYBRID BAJRA SEEDS 19
Slide 17: Farmers on Akhand
~ ~~ Farmers on “Akhand” aomlel cht feds Um decelat cate Yairdt e, frends thet sod Tee ciel UT eld e. bei de Ud disigd acl b aleul cidd Uedect h fee sug é ale sus atatcr ait saeeadé. 20
Slide 18: Q1FY25 Performance
Q1FY25 PERFORMANCE 17
Slide 19: Key Business Highlights
Key Business Highlights • Paddy hybrid strategy remains effective • Super 27 Bajra surges by 13% in value. Crop Performance • Maize products show volume growth despite of 29% despite revenue contribution at 4% in overall sales Strategic Focus • Future strategy emphasizes continued focus on maize and
Slide 20: Key Operating and Financial Highlights
Key Operating and Financial Highlights • Incremental Revenue Growth on QoQ basis • Cotton paddy segment volume decreased but revenue-maintained highlighting company’s efforts to focus on more high value product in portfolio Operating Performance • NCP segment increase by 19% in volume contributing 3
Slide 21: Segmental Revenue Contribution
Segmental Revenue Contribution Q1FY25 Revenue Q1FY24 Revenue INR 2,439 Mn INR 2,353 Mn Cotton,38% Cotton, 41% Others,30% Others, 27% Paddy ,32% Paddy, 32% Cotton Paddy Others Cotton Paddy Others • Others include: Jowar, Bajra, Maize, Mustard, Wheat 20
Slide 22: Income Statement
Income Statement %Change (YoY) Particulars (INR Mn) Q1FY25 Q1FY24 %Change (YoY) FY24 FY23 Total Revenue 2,439 2,353 -4% 3,326 3,013 10% Gross Profit 1,210 1,215 0% 1,991 1,667 19% Gross Margin (%) 49.6% 47.8% 60% 55% EBITDA 365 368 -0.81% 504 489 3% EBITDA Margin (%) 14.9% 15.6% 15% 16% Depreciation
Slide 23: Appendix
APPENDIX 22
Slide 24: Historical Income Statement
Historical Income Statement Nath Bio-Genes’ P&L Statement Particulars (INR Mn) FY24 FY23 FY22 FY21 FY20 Total Revenue 3,326 3,013 2,783 3,076 2,799 Gross Profit 1,991 1,667 1,544 1,715 1,536 Gross Margin (%) 60% 55% 56% 56% 55% EBITDA 504 489 373 667 547 EBITDA Margin (%) 15% 16% 13% 22% 20% Depreci
Slide 25: Historical Balance Sheet
Historical Balance Sheet Assets (INR Mn) FY24 FY23 FY22 FY21 FY20 Liabilities (INR Mn) FY24 FY23 FY22 FY21 FY20 Fixed Assets 2,406 2,340 2,329 2,333 2,308 Share Capital 190 190 190 190 190 Other Intangible 88 104 120 136 152 Assets Financial Assets 61 51 51 53 52 Reserves & Surplus 5,917 5,544 5,230
Slide 26: Maintaining Profitability; Strong Balance Sheet
Maintaining Profitability; Strong Balance Sheet Net Debt (INR Mn) Net Worth (INR Mn) 6,133 6,107 5,576 5,734 888 5,420 5,076 4,692 679 659 672 576 478 3,033 363 328 207 1,071 1,213 -121 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY15 FY16 FY17 FY18 FY19 FY20 FY21 FY22 FY23 FY24 EBITDA Margin
Slide 27: Visionary Leadership; Attracting the Best Talent
Visionary Leadership; Attracting the Best Talent > a P a Bo. ap Ty Mr. Nandkishor Kagliwal Mr. Satish Kagliwal Chairman Managing Director f Capt (Dr.) Devinder Khurana Dr. S. K. Raina Dr. V. N. Kulkarni Mr. Harish Pande CFO. Head-Genetic Research Head-R& D Head-Supply Chain Business Lead Nath Promot
Slide 28: Thank You
Thank You CIN_NBIL_L01110MH1993PLC072842 For further information, please get in touch with: Sheetal Khanduja sheetal@GoIndiaadvisors.com M:+91 97693 64166 Deepika Sharma deepika@GoIndiaadvisors.com M:+918451029510 27
Nath Bio-Genes (India) — Q1 FY2025 Earnings Presentation on 6ix